ETrade Capital Management’s Pfizer PFE Stock Holding History

ETrade Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$11M	Buy	316,499 +30,122	+11%	+$1.06M	0.21%	55
2020 Q2	$8.88M	Sell	286,377 -13,546	-5%	-$460K	0.19%	60
2020 Q1	$9.29M	Sell	299,923 -2,784	-0.9%	-$94.9K	0.24%	47
2019 Q4	$11.3M	Buy	302,707 +54,974	+22%	+$1.96M	0.25%	42
2019 Q3	$8.45M	Buy	247,733 +130,851	+112%	+$4.76M	0.21%	54
2019 Q2	$4.8M	Buy	116,882 +14,728	+14%	+$585K	0.13%	85
2019 Q1	$4.12M	Sell	102,154 -118,487	-54%	-$4.75M	0.12%	94
2018 Q4	$9.14M	Sell	220,641 -37,073	-14%	-$1.54M	0.3%	35
2018 Q3	$10.8M	Buy	257,714 +13,580	+6%	+$523K	0.31%	32
2018 Q2	$8.4M	Sell	244,134 -8,451	-3%	-$289K	0.26%	38
2018 Q1	$8.51M	Sell	252,585 -16,418	-6%	-$564K	0.27%	32
2017 Q4	$9.24M	Buy	269,003 +42,826	+19%	+$1.46M	0.3%	32
2017 Q3	$7.66M	Buy	226,177 +6,879	+3%	+$221K	0.27%	29
2017 Q2	$6.99M	Sell	219,298 -11,164	-5%	-$352K	0.27%	29
2017 Q1	$7.48M	Buy	230,462 +29,193	+15%	+$920K	0.31%	27
2016 Q4	$6.2M	Buy	201,269 +22,559	+13%	+$689K	0.28%	28
2016 Q3	$5.74M	Sell	178,710 -16,081	-8%	-$538K	0.28%	30
2016 Q2	$6.51M	Sell	194,791 -1,322	-0.7%	-$42.2K	0.34%	28
2016 Q1	$5.51M	Buy	196,113 +4,538	+2%	+$130K	0.31%	30
2015 Q4	$5.87M	Buy	191,575 +2,796	+1%	+$88K	0.34%	25
2015 Q3	$5.63M	Buy	188,779 +11,335	+6%	+$363K	0.35%	26
2015 Q2	$5.64M	Sell	177,444 -4,414	-2%	-$144K	0.33%	27
2015 Q1	$6M	Buy	181,858 +3,268	+2%	+$104K	0.36%	25
2014 Q4	$5.28M	Buy	178,590 +1,746	+1%	+$50.1K	0.32%	25
2014 Q3	$4.96M	Buy	176,844 +2,109	+1%	+$59.2K	0.32%	25
2014 Q2	$4.92M	Buy	174,735 +13,124	+8%	+$374K	0.33%	27
2014 Q1	$4.92M	Buy	161,611 +10,292	+7%	+$307K	0.35%	24
2013 Q4	$4.4M	Buy	151,319 +28,276	+23%	+$823K	0.35%	25
2013 Q3	$3.35M	Buy	123,043 +24,719	+25%	+$673K	0.31%	31
2013 Q2	$2.61M	Buy	+98,324	New	+$2.72M	0.28%	27

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ETrade Capital Management's PFE Position: Q3 2020 in Review

ETrade Capital Management increased its Pfizer (PFE) stake by 11% in Q3 2020, buying an estimated $1.06M and bringing the position to 316,499 shares worth $11M. The position accounts for 0.21% of the portfolio, ranked #55.

ETrade Capital Management first reported a position in PFE in Q2 2013 and has held it in 30 quarters since. The position peaked at $11.3M in Q4 2019. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

ETrade Capital Management held 316,499 shares of Pfizer worth $11M as of Q3 2020.
ETrade Capital Management bought 30,122 Pfizer shares in Q3 2020, an estimated $1.06M.
Pfizer made up 0.21% of ETrade Capital Management's portfolio in Q3 2020, its #55 holding.
ETrade Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 30 quarters since.
ETrade Capital Management's Pfizer position peaked at $11.3M in Q4 2019.
2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.